| Title |
Preventive treatment in migraine and the new US guidelines
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, May 2013
|
| DOI | 10.2147/ndt.s33769 |
| Pubmed ID | |
| Authors |
Emad Estemalik, Stewart Tepper |
| Abstract |
Migraine headaches are among the most common headache disorders seen in various practices. The prevalence of migraine headaches is 18% in women and 6% in men. While millions of Americans suffer from migraine headaches, roughly 3%-13% of identified migraine patients are on preventive therapy, while an estimated 38% actually need a preventive agent. The challenge among physicians is not only when to start a daily preventive agent but which preventive agent to choose. Circumstances warranting prevention have been described in the past, and in 2012, a new set of guidelines with an evidence review on preventive medications was published. A second set of guidelines provided evidence on nonsteroidal anti-inflammatory drugs, herbs, minerals, and vitamins for prevention of episodic migraine. This article describes the updated US guidelines for the prevention of migraines and also outlines the major studies from which these guidelines were derived. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 33% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 186 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 26 | 14% |
| Other | 21 | 11% |
| Student > Master | 20 | 10% |
| Student > Doctoral Student | 19 | 10% |
| Researcher | 18 | 9% |
| Other | 43 | 23% |
| Unknown | 44 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 23 | 12% |
| Agricultural and Biological Sciences | 13 | 7% |
| Nursing and Health Professions | 10 | 5% |
| Neuroscience | 9 | 5% |
| Other | 22 | 12% |
| Unknown | 51 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2020.
All research outputs
#4,812,358
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#645
of 3,120 outputs
Outputs of similar age
#38,513
of 204,726 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#10
of 53 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,726 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.